tiprankstipranks
Applied Therapeutics Faces FDA Challenges with Govorestat
PremiumCompany AnnouncementsApplied Therapeutics Faces FDA Challenges with Govorestat
19d ago
Applied Therapeutics downgraded to Neutral from Buy at UBS
Premium
The Fly
Applied Therapeutics downgraded to Neutral from Buy at UBS
20d ago
Applied Therapeutics price target lowered to $5 from $14 at Baird
Premium
The Fly
Applied Therapeutics price target lowered to $5 from $14 at Baird
20d ago
Voyager upgraded, HP downgraded: Wall Street’s top analyst calls
PremiumThe FlyVoyager upgraded, HP downgraded: Wall Street’s top analyst calls
23d ago
Voyager rises after upgrade, Applied plunges after CRL: Morning Movers
Premium
The Fly
Voyager rises after upgrade, Applied plunges after CRL: Morning Movers
23d ago
Applied Therapeutics CRL a ‘major setback,’ says William Blair
Premium
The Fly
Applied Therapeutics CRL a ‘major setback,’ says William Blair
23d ago
Applied Therapeutics trading halted, news pending
PremiumThe FlyApplied Therapeutics trading halted, news pending
24d ago
Applied Therapeutics price target raised to $13 from $11 at Citi
Premium
The Fly
Applied Therapeutics price target raised to $13 from $11 at Citi
24d ago
RBC says if Applied’s govorestat were to be approved, would likely hear today
Premium
The Fly
RBC says if Applied’s govorestat were to be approved, would likely hear today
25d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100